Literature DB >> 20451187

Pregnancy-related fibroid reduction.

Shannon K Laughlin1, Amy H Herring, David A Savitz, Andrew F Olshan, Julia R Fielding, Katherine E Hartmann, Donna D Baird.   

Abstract

We tested the hypothesis that the protective effect of parity on fibroids is due to direct pregnancy-related effects by following women from early pregnancy to postpartum period with ultrasound. Of 171 women with one initial fibroid, 36% had no identifiable fibroid at the time of postpartum ultrasound, and 79% of the remaining fibroids decreased in size.
Copyright © 2010 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20451187      PMCID： PMC2927730          DOI： 10.1016/j.fertnstert.2010.03.035

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  19 in total

1.  Changes in uterine size after vaginal delivery and cesarean section determined by vaginal sonography in the puerperium.

Authors:  H Negishi; T Kishida; H Yamada; E Hirayama; M Mikuni; S Fujimoto
Journal:  Arch Gynecol Obstet       Date:  1999-11       Impact factor: 2.344

2.  Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study.

Authors:  A Aharoni; A Reiter; D Golan; Y Paltiely; M Sharf
Journal:  Br J Obstet Gynaecol       Date:  1988-05

3.  Why is parity protective for uterine fibroids?

Authors:  Donna Day Baird; David B Dunson
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

4.  Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy.

Authors:  Jerzy A Walocha; Jan A Litwin; Adam J Miodoński
Journal:  Hum Reprod       Date:  2003-05       Impact factor: 6.918

5.  Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study.

Authors:  P Rosati; C Exacoustòs; S Mancuso
Journal:  J Ultrasound Med       Date:  1992-10       Impact factor: 2.153

Review 6.  Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology?

Authors:  Fred Burbank
Journal:  J Am Assoc Gynecol Laparosc       Date:  2004-05

7.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

8.  Recruitment for a community-based study of early pregnancy: the Right From The Start study.

Authors:  Joanne H E Promislow; Christina M Makarushka; Jessica R Gorman; Penelope P Howards; David A Savitz; Katherine E Hartmann
Journal:  Paediatr Perinat Epidemiol       Date:  2004-03       Impact factor: 3.980

9.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

10.  Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.

Authors:  Shannon K Laughlin; Donna D Baird; David A Savitz; Amy H Herring; Katherine E Hartmann
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623
View more
  24 in total

1.  Self-report versus ultrasound measurement of uterine fibroid status.

Authors:  Sharon L Myers; Donna Day Baird; Andrew F Olshan; Amy H Herring; Jane C Schroeder; Leena A Nylander-French; Katherine E Hartmann
Journal:  J Womens Health (Larchmt)       Date:  2011-11-01       Impact factor: 2.681

2.  Postpartum factors and natural fibroid regression.

Authors:  Shannon K Laughlin; Katherine E Hartmann; Donna D Baird
Journal:  Am J Obstet Gynecol       Date:  2011-04-14       Impact factor: 8.661

3.  BET1L and TNRC6B associate with uterine fibroid risk among European Americans.

Authors:  Todd L Edwards; Kara A Michels; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-04-19       Impact factor: 4.132

Review 4.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

5.  Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.

Authors:  Tomoko Kaneko-Tarui; Arno E Commandeur; Amanda L Patterson; Justin L DeKuiper; David Petillo; Aaron K Styer; Jose M Teixeira
Journal:  Mol Hum Reprod       Date:  2014-09-04       Impact factor: 4.025

Review 6.  Uterine leiomyomas: individualizing the approach to a heterogeneous condition.

Authors:  Shannon K Laughlin; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

Review 7.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

8.  A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.

Authors:  D D Baird; T M Saldana; D L Shore; M C Hill; J M Schectman
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

9.  Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans.

Authors:  Todd L Edwards; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-07-28       Impact factor: 4.132

10.  Self-reported bacterial vaginosis and risk of ultrasound-diagnosed incident uterine fibroid cases in a prospective cohort study of young African American women.

Authors:  Kristen R Moore; Donna D Baird
Journal:  Ann Epidemiol       Date:  2017-10-13       Impact factor: 3.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.